Back
  1. Home
  2. Profile of Patrick Papart (ULiège)
Profil

Papart Patrick

Département des sciences cliniques > Psycho. quantitative - Psychiatrie légale et sociale

PNE

See author's contact details
Main Referenced Co-authors
Ansseau, Marc  (45)
Pitchot, William  (17)
Timsit-Berthier, Martine  (11)
Von Frenckell, Remy  (10)
Hansenne, Michel  (9)
Main Referenced Keywords
Depression (7); Adult (5); Humans (5); Male (5); Female (4);
Main Referenced Unit & Research Centers
Centre de Neurosciences Cognitives et Comportementales - ULiège [BE] (3)
Main Referenced Disciplines
Psychiatry (26)
Treatment & clinical psychology (15)
Neurosciences & behavior (9)
Neurology (1)

Publications (total 47)

The most downloaded
1051 downloads
Ansseau, M., Devoitille, J.-M., Papart, P., Vanbrabant, E., Mantanus, H., & Timsit-Berthier, M. (1991). Comparison of Adinazolam, Amitriptyline, and Diazepam in Endogenous Depressive Inpatients Exhibiting Dst Nonsuppression or Abnormal Contingent Negative Variation. Journal of Clinical Psychopharmacology, 11 (3), 160-165. doi:10.1097/00004714-199106000-00003 https://hdl.handle.net/2268/258197

The most cited

72 citations (Scopus®)

Ansseau, M., Legros, J.-J., Mormont, C., Cerfontaine, J.-L., Papart, P., Geenen, V., & Franck, G. (1987). Intranasal oxytocin in obsessive-compulsive disorder. Psychoneuroendocrinology, 12, 231-236. doi:10.1016/0306-4530(87)90009-6 https://hdl.handle.net/2268/23677

HITABATUMA, H., Papart, P., WAUTHY, J., BARTHOLOME, F., & Ansseau, M. (2011). Le modèle psychologique de Cloninger (TCI) et la dépression. Acta Psychiatrica Belgica, 111 (3), 34-38.
Peer Reviewed verified by ORBi

Papart, P., Ansseau, M., & Bartholomé, F. (2008). Contingent negative variation abnormalities in posttraumatic stress disorder. European Neuropsychopharmacology, 18 (Suppl 4), 481-482.
Peer Reviewed verified by ORBi

Papart, P., Liota, F., Bartholome, F., & Ansseau, M. (September 2006). Cognitive topography imbalance in alcoholism and psychiatric comorbidity. European Neuropsychopharmacology, 16 (Suppl. 4), 496. doi:10.1016/S0924-977X(06)70671-X
Peer Reviewed verified by ORBi

Papart, P., Liota, F., Bartholomé, F., & Ansseau, M. (September 2003). Cognitive topography imbalance in alcoholism. Journal of Psychophysiology, 17 (Suppl 1), 7-8.
Peer reviewed

Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Papart, P., & Ansseau, M. (2000). P300 event-related brain potential and personality in depression. European Psychiatry, 15 (6), 370-7. doi:10.1016/S0924-9338(00)00505-8
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Pinto, E., Papart, P., & Ansseau, M. (2000). Serotonergic-1a activity and contingent negative variation. Biological Psychology, 52 (3), 259-65. doi:10.1016/S0301-0511(99)00047-2
Peer Reviewed verified by ORBi

Papart, P., WEERTS, P., Pinto, E., Hansenne, M., & Ansseau, M. (2000). Relationship between CNV topography and irritability in depression. Journal of Psychophysiology, 14 (Suppl 1).
Peer reviewed

Papart, P. (1999). Troubles psychiatriques et dangerosité. Acta Psychiatrica Belgica, 99, 229-238.
Peer Reviewed verified by ORBi

Hansenne, M., PITCHOT, W., Papart, P., & ANSSEAU, M. (1998). Serotonergic modulation of the P300 event related brain potential. Human Psychopharmacology, 13 (4), 239-243. doi:10.1002/(SICI)1099-1077(199806)13:4<239::AID-HUP986>3.0.CO;2-V
Peer Reviewed verified by ORBi

Papart, P., Ansseau, M., & Timsit-Berthier, M. (1997). Influence of Diazepam on Contingent Negative Variation. Human Psychopharmacology, 12, 95-98. doi:10.1002/(SICI)1099-1077(199703/04)12:2<95::AID-HUP841>3.0.CO;2-3
Peer Reviewed verified by ORBi

Papart, P., Ansseau, M., & Timsit-Berthier, M. (1996). CNV in mood disorders. In Recent advances in event-related brain potential research (pp. 897-900). Elsevier Science.
Peer reviewed

Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Papart, P., Timsit-Berthier, M., & Ansseau, M. (1995). Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines). Electroencephalography and Clinical Neurophysiology, 96 (2), 194-196. doi:10.1016/0168-5597(94)00317-8
Peer Reviewed verified by ORBi

Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Lembreghts, M., Hansenne, M., Wauthy, J., Reel, C., Jammaer, R., Papart, P., Sulon, J., & Legros, J.-J. (1995). The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior. Pharmacopsychiatry, 28 (Suppl. 2), 91-92. doi:10.1055/s-2007-979625
Peer Reviewed verified by ORBi

Papart, P. (1994). Dépression: Intérêt de la variation contingente négative. Dialogue/Depression.
Peer reviewed

Ansseau, M., Papart, P., Troisfontaines, B., Bartholome, F., Bataille, M., Charles, G., Schittecatte, M., Darimont, P., Devoitille, J. M., & De Wilde, J. (February 1994). Controlled Comparison of Milnacipran and Fluoxetine in Major Depression. Psychopharmacology, 114 (1), 131-7. doi:10.1007/BF02245454
Peer Reviewed verified by ORBi

Ansseau, M., PITCHOT, W., Hansenne, M., WAUTHY, J., Moreno, A. G., Jammaer, R., Réel, C., Lembreghts, M., Papart, P., Gros-Gean, J., Devroye, A., Sulon, J., & Legros, J.-J. (1994). The flesinoxan/5-HT1A receptor challenge and suicidal behavior. European Neuropsychopharmacology, 4 (3), 322-323. doi:10.1016/0924-977X(94)90138-4
Peer Reviewed verified by ORBi

ANSSEAU, M., Gabriëls, A., Loyens, J., Bartholomé, F., Evrard, J. L., De Nayer, A., Linhart, R., Wirtz, J., Bruynooghe, F., Surinx, K., Clarysse, H., Marganne, R., & Papart, P. (1994). Controlled comparison of paroxetine and fluvoxamine in major depression. Human Psychopharmacology, 9 (5), 329-336. doi:10.1002/hup.470090502
Peer Reviewed verified by ORBi

Papart, P., ANSSEAU, M., & Timsit-Berthier, M. (1994). Contingent negative variation (CNV) in mood disorders. European Neuropsychopharmacology, 4 (3), 323. doi:10.1016/0924-977x(94)90139-2
Peer Reviewed verified by ORBi

Schittecatte, M., Charles, G., Machowski, R., Dumont, F., Garcia-Valentin, J., Wilmotte, J., Papart, P., PITCHOT, W., WAUTHY, J., Ansseau, M., Pelc, I., & Hoffman, G. (1994). Effect of gender and diagnostic on growth hormone response to clonidine for major depression : A large scale multicenter study. American Journal of Psychiatry, 151 (2), 216-220. doi:10.1176/ajp.151.2.216
Peer Reviewed verified by ORBi

ANSSEAU, M., Gabriëls, A., Loyens, J., Bartholomé, F., Evrard, J.-L., De Nayer, A. R., Linhart, R., Wirtz, J., Bruynoghe, F., Surinx, K., Clarysse, H., Marganne, R., & Papart, P. (1993). A double-blind comparison of paroxetine and fluvoxamine in major depression. European Neuropsychopharmacology, 3 (3), 323-324. doi:10.1016/0924-977x(93)90099-8
Peer Reviewed verified by ORBi

ANSSEAU, M., Troisfontaines, B., Papart, P., & von Frenckell, R. (1993). Compulsive personality and serotonergic drugs. European Neuropsychopharmacology, 3 (3), 288-289. doi:10.1016/0924-977X(93)90077-Y
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., Papart, P., Gonzalez Moreno, A., Timsit-Berthier, M., & LEGROS, J.-J. (1993). Intérêt des marqueurs biologiques de dépression dans le choix du traitement antidépressif. Médecine et Hygiène, 51 (1990), 1970-1976.
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., Gonzalez Moreno, A., Papart, P., & WAUTHY, J. (1993). Pilot study of flesinoxan in major depression. Effect on REM latency and body temperature. Human Psychopharmacology, 8 (4), 279-283. doi:10.1002/hup.470080407
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., Gonzalez-Moreno, A., Papart, P., Gerritsen van der Hoop, R., & Bradford, D. (1992). Flesinoxan, a 5-HT1A agonist, in major depression: Clinical efficacy and effects on rem latency and body temperature (open study). European Neuropsychopharmacology, 2 (3), 313. doi:10.1016/0924-977X(92)90153-Y
Peer Reviewed verified by ORBi

ANSSEAU, M., PAPART, P., PITCHOT, W., Timsit-Berthier, M., Legros, J.-J., & von Frenckell, R. (1992). Dexamethasone suppression test and prediction of treatment response to selective antidepressants. European Psychiatry, 7 (4), 191-194.
Peer Reviewed verified by ORBi

Schittecatte, M., ANSSEAU, M., Charles, G., Machowski, R., Papart, P., PITCHOT, W., & Wilmotte, J. (1992). Growth hormone response to clonidine in male untreated panic patients. Psychological Medicine, 22 (4), 1059-1062. doi:10.1017/s0033291700038630
Peer Reviewed verified by ORBi

PITCHOT, W., Ansseau, M., Réel, C., Gonzalez Moreno, A., Papart, P., & Hansenne, M. (1992). Red blood cell folate and suicidal behavior. European Neuropsychopharmacology, 2 (3), 306-307. doi:10.1016/0924-977X(92)90143-V
Peer Reviewed verified by ORBi

PITCHOT, W., Gonzalez Moreno, A., Ansseau, M., Hansenne, M., & Papart, P. (1992). Clonidine test in bipolar vs unipolar melancholic patients. European Neuropsychopharmacology, 2 (3), 306. doi:10.1016/0924-977X(92)90142-U
Peer Reviewed verified by ORBi

Ansseau, M., Pitchot, W., Papart, P., Gonzalez Moreno, A., Lembreghts, M., & Legros, J.-J. (1992). Neuroendocrine Factors in Affective Disorders. Clinical Neuropharmacology, 15 (Suppl 1 Pt A), 574A-575. doi:10.1097/00002826-199201001-00299
Peer Reviewed verified by ORBi

Ansseau, M., Troisfontaines, B., Papart, P., & von Frenckell, R. (28 September 1991). Compulsive Personality as Predictor of Response to Serotoninergic Antidepressants. BMJ: British Medical Journal, 303 (6805), 760-1. doi:10.1136/bmj.303.6805.760
Peer Reviewed verified by ORBi

PITCHOT, W., ANSSEAU, M., Gonzales Moreno, A., Papart, P., Gerritsen van der Hoop, R., & Bradford, D. (1991). Pilot study of flesinoxan, a 5-HT1A agonist, in major depression. European Neuropsychopharmacology, 1 (3), 436. doi:10.1016/0924-977x(91)90641-7
Peer Reviewed verified by ORBi

Ansseau, M., Devoitille, J.-M., Papart, P., Vanbrabant, E., Mantanus, H., & Timsit-Berthier, M. (1991). Comparison of Adinazolam, Amitriptyline, and Diazepam in Endogenous Depressive Inpatients Exhibiting Dst Nonsuppression or Abnormal Contingent Negative Variation. Journal of Clinical Psychopharmacology, 11 (3), 160-165. doi:10.1097/00004714-199106000-00003
Peer Reviewed verified by ORBi

Papart, P., ANSSEAU, M., & Timsit-Berthier, M. (1991). Contingent Negative Variation and response to antidepressants. European Neuropsychopharmacology, 1 (3), 461. doi:10.1016/0924-977X(91)90679-O
Peer Reviewed verified by ORBi

Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., & Papart, P. (1991). Pilot Study of Pk 11195, a Selective Ligand for the Peripheral-Type Benzodiazepine Binding Sites, in Inpatients with Anxious or Depressive Symptomatology. Pharmacopsychiatry, 24 (1), 8-12. doi:10.1055/s-2007-1014425
Peer Reviewed verified by ORBi

Papart, P., & ANSSEAU, M. (1990). Milnacipran in obsessive-compulsive disorder: Study in one case. Psychiatrie et Psychobiologie, 5 (5), 325-327.
Peer Reviewed verified by ORBi

Ansseau, M., Papart, P., Gérard, M.-A., von Frenckell, R., & Franck, G. (1990). Controlled Comparison of Buspirone and Oxazepam in Generalized Anxiety. Neuropsychobiology, 24 (2), 74-78. doi:10.1159/000119464
Peer Reviewed verified by ORBi

Papart, P., & Ansseau, M. (1990). Milnacipran et trouble obsessionnel-compulsif: étude d'un cas. Psychiatrie et Psychobiologie, 5 (5), 325-327.
Peer Reviewed verified by ORBi

Papart, P., Ansseau, M., Devoitille, J. M., Mantanus, H., & Timsit-Berthier, M. (1990). Contingent negative variation and severity of depression. In Psychiatry: A world perspective - Volume 2 (pp. 402-408). Elsevier Science Publishers.
Peer reviewed

ANSSEAU, M., von Frenckell, R., Papart, P., Mertens, C., De Wilde, J., Botte, L., Devoitille, J.-M., Evrard, J. L., De Nayer, A., Koch‐Bourdouxhe, S., Darimont, P., Lecoq, A., Mirel, J., Couzinier, J. P., Demarez, J. P., & Serre, C. (1989). Controlled comparison of milnacipran (F2207) 200 mg and amitriptyline in endogenous depressive inpatients. Human Psychopharmacology, 4 (3), 221-227. doi:10.1002/hup.470040308
Peer Reviewed verified by ORBi

PITCHOT, W., ANSSEAU, M., PAPART, P., Franck, G., & Rorive, G. (1989). Hyponatrémie induite par la carbamazépine et affection rénale : à propos d'un cas. Psychiatrie et Psychobiologie, 4 (4), 235-237. doi:10.1017/S0767399X00002807
Peer Reviewed verified by ORBi

Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J.-J. (1988). Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. British Journal of Psychiatry, 153 (1), 65-71. doi:10.1192/bjp.153.1.65
Peer Reviewed verified by ORBi

Papart, P., & Ansseau, M. (1987). Echelle manie-depression de l'AMDP et inversion maniaque. Psychiatrie et Psychobiologie, II (3).
Peer Reviewed verified by ORBi

Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J.-J. (1987). Neuroendocrine evaluation of catecholaminergic neurotransmission in mania. Psychiatry Research, 22 (3), 193-206. doi:10.1016/0165-1781(87)90034-5
Peer Reviewed verified by ORBi

ANSSEAU, M., Cerfontaine, J.-L., von Frenckell, R., Charles, G., Papart, P., & Franck, G. (1987). L'index de Newcastle pour le diagnostic de dépression endogène : Comparaison avec les critères de diagnostic pour la recherche de dépression majeure. Encéphale (L'), 13 (2), 67-72.
Peer Reviewed verified by ORBi

Ansseau, M., Legros, J.-J., Mormont, C., Cerfontaine, J.-L., Papart, P., Geenen, V., & Franck, G. (1987). Intranasal oxytocin in obsessive-compulsive disorder. Psychoneuroendocrinology, 12, 231-236. doi:10.1016/0306-4530(87)90009-6
Peer Reviewed verified by ORBi

Demey-Ponsart, E., Ansseau, M., Sulon, J., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Geenen, V., & Legros, J.-J. (1987). Diagnostic performance of basal free cortisol/18-hydroxy-11-deoxy-corticosterone (18-OH-DOC) ratio in endogenous depression: comparison with the dexamethasone suppression test. Biological Psychiatry, 22 (8), 947-956. doi:10.1016/0006-3223(87)90004-7
Peer Reviewed verified by ORBi

Papart, P., Ansseau, M., Cerfontaine, J.-L., & Franck, G. (May 1986). Adinazolam-Induced Mania. American Journal of Psychiatry, 143 (5), 684-685. doi:10.1176/ajp.143.5.684-a
Peer Reviewed verified by ORBi

Contact ORBi